Solizmestrocel for erectile dysfunction

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 29 Dec 2025: Trial started, NCT07480161
  2. 18 Mar 2026: Trial registered, NCT07480161

The trials

NCT07480161: Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction

State
Under way
Phase
Phase 2 and Phase 3
People
90 planned
Started
29 Dec 2025
Primary completion
29 Dec 2027
Arms
Mesenchymal Stem Cell Treatment Group
Results
None posted
  1. 29 Dec 2025: Trial started
  2. 18 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Human Allogenic Umbilical Cord Mesenchymal Stromal Cells, Subjects in the UC-MSC treatment group will receive two intravenous infusions (at day 0 and 3) of 100 million UC-MSC., Uc-msc, Umbilical Cord-Derived Mesenchymal Stem Cells, XytriX.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.